Prof. Dr. Mesut Çetin’in Kısa Yayın Listesi- 2010
1. Cetin M, Ebrinc S, Agargun MY, Yigit S. Risperidone for the treatment of monosymptomatic hypochondriacal psychosis. J Clin Psychiatry 1999; 60: 554.
2. Basoglu C, Cetin M, Semiz UB, AgargUn MY, Ebrinc S. Premenstrual exacerbation and suicidal behavior in patients with panic disorder. Compr Psychiatry 2000; 41: 103-106.
3. Ebrinc S, Top C, OncUl O, Basoglu C, Cavuslu S, Cetin M. Serum interleukin-1 alpha and interleukin-2 levels in patients with schizophrenia. J Int Med Res 2002; 30: 314-317.
4. Uzun O, Basoglu C, Cansever A, Ozsahin A, Cetin M, Ebrinc S.: Body dysmorphic disorder in patients with acne. Compr Psychiatry. 2003 Sep-Oct;44(5):415-9.
5. Gultepe M, Ozcan O, Avsar K, Cetin M, Ozdemir AS,Gok M.Urine methylmalonic acid measurements for assessment of cobalamin deficiency related to neuropsychiatric disorders. Clin Biochem 2003;36:275-282.
6. Semiz UB, Turhan V, Basoglu C, Oner O, Ebrinc S, Cetin M. Leptospirosis presenting with mania and psychosis: four consecutive cases seen in a military hospital in Turkey. Int J Psychiatr Med 2005; 35: 299-305
7. Semiz UB, Basoglu C, Cetin M, Ebrinc S. Panic disorder due to ingestion of single dose ecstasy. Int J Psychiatr Clin Pract 2005; 9: 138-141.
8. Semiz UB, Senol MG, Basoglu C, Noyan O, Ebrinc S, Cetin M, Saracoglu M. Relationship of depressive symptoms and subjective sleep disturbances to the quality of life in patients with Parkinson’s disease. Neurol Psychiatr Brain Res 2007; 14: 55-58
9. Semiz UB, Basoglu C, Ebrinc S, Cetin M. Childhood trauma history and dissociative experiences among Turkish men diagnosed with antisocial personality disorder. Soc Psychiatry Psychiatr Epidemiol 2007; 42: 865-873
10. Semiz UB, Cetin M, Basoglu C, Ebrinc S, Uzun O, Herken H, Balibey H, Algul A, Ates A. Clinical predictors of therapeutic response to clozapine in a sample of Turkish patients with treatment-resistant schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31: 1330-1336.
11. Gulsun M, Algul A, Semiz UB, Ates MA, Doruk A, Ebrinc S, Basoglu C, Cetin M. A case with euprolactinemic galactorrhea ınduced by escitalopram. Int J Psychiatr Med 2007; 37: 275-278.
12. Ebrinc S, Semiz UB, Basoglu C, Cetin M, Agargun MY, Algul A, Ates A, Self-mutilating behavior in patients with disociative disorders: the role of ınnate hypnotic capacity. Isr J Psychiatry Relat Sci 2008:45: 43-52
13. Algul A, Semiz UB, Dundar O, Ates MA, Basoglu C, Ebrinc S, Doruk A, Gecici O, Cetin M. Psychosocial and hormone related risk factors for early postnatal depressive symptoms in turkish women. Neurology, Psychiatry and Brain Research 2008:15: 117-122 ().
14. Semiz UB, Basoglu C, Ebrinc S, Cetin M. Nightmare disorder, dream anxiety, and subjective sleep quality in patients with borderline personality disorder. Psychiatry Clin Neurosci 2008: 62: 48-55
15. Semiz U, Basoglu C, Cetin M, Ebrinc S, Uzun O, Ergun B. Body dysmorphic disorder in patients with borderline personality disorder: prevalence, clinical characteristics, and role of childhood trauma. Acta Neuropsychiatrica 2008: 20: 33-40
16. Basoglu C, Semiz U, Oner O. Gunay H, Ebrinc S, Cetin M, Sildiroglu O, Algul A, Ates A, Sonmez G. A magnetic resonance spectroscopy study of antisocial behavior disorder, psychopathy and violent crime among military conscripts. Acta Neuropsychiatrica 2008: 20: 72-77
17. Semiz U, Basoglu C, Oner O, Munir K, Ebrinc S, Cetin M. Effects of diagnostic comorbidity and dimensional symptoms of attention deficit hyperactivity disorder in males with antisocial personality disorder. Aust N Z J Psychiatry 2008: 42: 405-413
18. Semiz UB, Algul A, Basoglu C, Ates MA, Ebrinc S, Cetin M, Gunes C, Gunay H. Relationship of subjective sleep quality to aggression in male subjects with antisocial personality disorder. Turk Psikiyatri Derg 2008: 19: 373-381
19. Ebrinc S, Algul A, Ates MA, Semiz UB, Gecici O, Basoglu C, Cetin M. Efficacy and safety of long-acting injectable risperidone during treatment of manic episode with non-compliance bipolar patients. Neurol Psychiatr Brain Res 2008: 15: 38-44
20. Barlas IO, Cetin M, Erdal ME, Semiz UB, Basoglu C, Ay ME, Herken H, Uzun O. Lack of association between DRD3 gene polymorphism and response to clozapine in Turkish schizoprenia patients. Am J Med Genet B Neuropsychiatr Genet 2008 Apr 30.
21. Ates MA, Algul A, Gecici O, Semiz UB, Noyan O, Basoglu C, Ebrinc S, Uzun O, Cetin M. Substance use in early adult male with first episode psychosis. Neurol Psychiatr Brain Res 2008: 15: 93-98
22. Algul A, Ates MA, Gulsun M, Semiz UB, Gecici O, Noyan O,Cetin M. epileptic seizure precipitated by using venlafaxine-extended release form: a case report. Noropsikiyatri Arsivi - Archives of Neuropsychiatry 2008; 45(2):62-64 ( in Turkish).
23. Cetin M, Antidepressants, antipsychotics: Reliability of metaanalyses.Klinik Psikofarmakoloji Bulteni –Bulletin of Clinical Psychopharmacology, 2008: 18(4):245-250 ( in Turkish).
24. Algul A, Ates MA, Gulsun M, Doruk A, Semiz UB, Basoglu C, Ebrinc S, Cetin M, The relationship between self-mutilation, aggression, childhood trauma history and dissociative experiences in antisocial personality disorder.Anadolu Psikiyatri Dergisi- Anatolinan Journal of Psychiarty 2009;10:278-285( in Turkish).
25. Korkmaz A, Ates MA, Algul A, Basoglu C, Physiological approach to neuropsychiatric diseases; role of autonomic nervous system and melatonin. Klinik Psikofarmakoloji Bulteni, Bulletin of Clinical Psychopharmacology 2009;19:173-182 ( in Turkish).
26. Ates MA, Algul A, Gulsun M,Geçici O, Ozdemir B, Basoglu C, Semiz UB, Servet h antisocial personality disorder Noropsikiyatri Arsivi - Archives of Neuropsychiatry 2009;46:135-139 ( in Turkish).
27. Ates MA, Algul A, Semiz UB, Gecici O, Basoglu C, Ebrinc S, Cetin M. Clinical characteristics of self-mutilating behavior in Turkish male subjects with antisocial personality disorder. International Journal of Social Psychiatry 2009 (
28. Algul A, Sen H, M. Ates, Yen T, Durmaz O, Ozkan S, Basoglu C, Semiz UB, Ebrinc S, Daglı G, Cetin M,. “ElektrokonvUlzif tedavide propofol ile propofol remifentanil kombinasyonun nobet suresi ve hemodinami Uzerine etkisi”, Klinik Psikofarmakoloji Bulteni, Bulletin of Clinical Psychopharmacology 2009;19, 24-28 ( in Turkish).
29. Basoglu C, M. Ates A, Algul A, İpçioglu M, Geçici O, Yılmaz O, Semiz UB, S Ebrinc S Gulsun M, Ozcan O, Kilic S, Cetin M.Adjuvant folate with escitalopram treatment and homocystein, folate, vitamin B-12 levels in patients with major depressive disorder Klinik Psikofarmakoloji Bulteni –Bulletin of Clinical Psychopharmacology 2009; 19(2):135-142 ( in Turkish).
30. Algul, A, Semiz UB, Basoglu C,Ebrinc S,Geçici O,Gulsun M,Kardesoglu E, Cetin M,Evaluation of general psychopathology, subjective sleep quality and health related quality of life in patients with obesity,In’l J Psychiatry in Med 2009;39: 297-312
31. Algul, A, Gulsun M, Geçici O,Ozdemir B, Basoglu C, Semiz UB, Ebrinc S,Cetin M, The relationship between alexithymia, aggression and psychopathy in young adult males with antisocial personality disorder.Noropsikiyatri Arsivi - Archives of Neuropsychiatry 2009; 46: 135-9 ( in Turkish).
32. Ates MA, Algul A, Semiz UB, Gecici O, Basoglu C, Ebrinc S, Cetin M.Clinical characteristics of self-mutilating behavior in Turkish male subjects with antisocial personality disorder: relationship to psychopathy. Int J Soc Psychiatry. 2009 Nov 11.
33. Cetin M, Aricioglu F, Pharmacovigilance and its significance in psychopharmacology,Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology, 2009; 19(4):335-339 ( in Turkish).
34. Cetin M,Aricioglu F, On the debate of original drug versus generic drug. Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology, 2009; 19(3):211-213 ( in Turkish).
35. Cetin M, Acikel C. In perspective of meta-analyses: Are all of the antidepressants similar? Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology, 2009; 19(2):87-92 ( in Turkish).
36. Cetin M, Kilic S . How to comprehend the recent meta-analyses conducted on typical and atypical antipsychotics?Klinik Psikofarmakoloji Bulteni –Bulletin of Clinical Psychopharmacology, 2009; 19(1):1-4 ( in Turkish).
37. Ates MA, Algul A, Semiz UB, Gecici O, Basoglu C, Ebrinc S, Cetin M. Clinical characteristics of self-mutilating behavior in Turkish male subjects with antisocial personality disorder: relationship to psychopathy. Int J Soc Psychiatry. 2009 Nov 11.
38. MacKay M, Cetin M, Baker G, Dursun S. Modulation of central nitric oxide as a therapeutic strategy for schizophrenia. Klinik Psikofarmakoloji Bulteni –Bulletin of Clinical Psychopharmacology, 2010; 20(2):115-119
39. Cetin M,, Aricioglu F. Pharmacoeconomics and its importance in psychiatry. Klinik Psikofarmakoloji Bulteni –Bulletin of Clinical Psychopharmacology, 2010; 20(1):1-4 ( in Turkish).
40. Basoglu C, Oner O, Ates AM, Algul A, Semiz UB, Ebrinc S, Cetin M, Ozcan O, Ipcioglu OM.Association between symptom improvement and change of body mass index, lipid profile, and leptin, ghrelin, and cholecystokinin levels during 6-week olanzapine treatment in patients with first-episode psychosis.J Clin Psychopharmacol. 2010;30(5):636-8.
41. Cetin M. Escitalopram treatment of fibromyalgia: a pilot study.European Psychiatry 2010;25, (Suppl 1) S 72
42. Cetin M,A comparative study of atypical antiosychotics on sexual dysfunction.International Journal of Neuropsychopharmacology, 2010; Vol 13 (Suppl. 1) S 89
43. Dursun S, Hallak J, Devarajan S, Baker G, Cetin M High-dose antipsychotic medication; a practical pocket checklist. Klinik Psikofarmakoloji Bulteni, Bulletin of Clinical Psychopharmacology 2010;20:187-188
44. Semiz UB, Algul, A, Cetin M.Alexithimia and aggression in patients with antisocial personality disorder. European Psychiatry 2008; 23: (Suppl.2) S91
45. Algul A, Semiz UB,Ates MA, Cetin M.Asssociation between psychosocial distress, subjective sleep qualityof life in patients with obesit: A preliminary study.European Psychiatry 2008; 23: (Suppl.2) S62-S63.
46. Ebrinc S, Sahan A, Semiz UB, Cetin M. Effect of sertraline treatment on regional cerebral blood flow in OCD. European Neuropsychopharmacology 2008;18: ( Suppl. 4) S62-S63.
47. Ebrinc S, Semiz UB, Oznur T, Cetin M. Neuropsychological assessment of unmadecated patients with OCD.European Neuropsychopharmacology 2008;18: ( Suppl. 4) S62-S63.
48. Basoglu C, Cetin M, Oner O.Comparison of rigth thalamus and temporal cortex metabolite levels of drug-naive first episode psychotic and chronic schizophrenia inpatiens. Turk Psikiyatri Dergisi 2006;17:8591.
49. Semiz U, Basoglu C, Cetin M, Ebrinc S, Uzun O, Ergun B. Body dysmorphic disorder in patients with borderline personality disorder: A preliminary study. European Neuropsychopharmacology 2005; 15: (Suppl.3) S651-S651.
50. Cetin M, Kose M, Ebrinc; Elhai .Identification and posttraumatic stres disorder symptoms in recue workers in Marmara, Turkey, earthquake. J Traumatic Stress 2005;18:485-489
51. Cetin M, Ebrinc S, Basoglu C, Semiz UB. Efficacy and safety of long-acting injectable risperidone in schizophrenia:a 12 week open-label study in stable patients switched from typical and atypical oral antipsychotics. European Neuropsychopharmacology 2005; 15: (Suppl.2) S134-S135.
52. Cetin M, Ebrinc S, Kandilcioglu H,et al. An invesyigation of some brain regions with proton magnetic resonance spectroscopy (1H-MRS) method in patients with first episode and chronic schizophrenia. European Neuropsychopharmacology 2004; 14: (Suppl.2) S239-S239.
53. Cetin M, Karagozoglu M.Olanzapine-induced metabolic side effects, swithing from olanzapine to ziprasidone: A pilot study European Psychiatry 2007; 22: (Suppl.1) S108-S108.
54. Cetin M, Ebrinc S, Basoglu C, Semiz UB.The efficacy and safety of olanzapine in combination with valproate or lithium in the treatment of mania. European Neuropsychopharmacology 2002; 12: (Suppl.3) S323-S323.
55. Basoglu C, Cetin M, Semiz UB. Hypnotizability, pain treshold and dissociative experiences in patients with borderline personality disorder and self-mutilating behavior. European Neuropsychopharmacology 2002; 12: (Suppl.3) S433-S434.
56. Aricioglu, F, Cetin M.Personalized drug therapy in psychiatry: Maybe a little old or a little new, but the treatment of future. Klinik Psikofarmakoloji Bulteni, Bulletin of Clinical Psychopharmacology 2010;20: 266-270 ( in Turkish).
|
|
1. Mesut ÇETİN. Psikomatik Perspektiften Allerjik Hastalıklar ve Bronşiyal Astma. Allerjik Hastalıklar ve Bronşiyal Astma/1. Cilt. Bilmedya Grup, İstanbul, 2004 Cilt I. sayfa:291-323.
2. Mesut Çetin, Bölüm 1.Psikiyatrinin Kısa Tarihi, Araştırma ve Klinik Uygulamada Biyolojik Psikiyatri,ŞİZOFRENİ. Editörler M.Emin Ceylan, Mesut Çetin, 3. baskı; Küre İletişim Grubu, İstanbul,2005, sayfa:1-65.
3. Mesut Çetin, M.Emin Ceylan, Bölüm 2.Genel Bilgiler, Araştırma ve Klinik Uygulamada Biyolojik Psikiyatri,ŞİZOFRENİ. Editörler M.Emin Ceylan, Mesut Çetin, 3. baskı; Küre İletişim Grubu, İstanbul,2005, sayfa:66-99.
4. Tarhan,N.,Çetin,M.: Depresyonda Biyolojik Göstergeler,Depresyon Monografları Serisi,.(Editor) Köroğlu E. Medikomat.Hekimler Yayın Birliğli,Ankara, 1993 Vol.4,sayfa:175-200.
5. Çetin M. Tarhan N.: Depresyonun Psikoendokrinolojisi, Depresyon Monografları Serisi.,. (Editor) Köroğlu E. Medikomat.Hekimler Yayın Birliğli,Ankara, 1993 Vol.6,sayfa:253-281.
6. Klinik Psikofarmakolojide Yenilikler-I "Ulusal Sempozyum" Kitabı, Editörler: Tarhan,N, Ceylan,ME, Çetin M, İstanbul,1991.
7. Çetin,M.,Evren C: Atipik Nöroleptikler. Klinik Psikofarmakolojide Yenilikler-IV "Uluslararası Katılımlı Sempozyum" Kitabı, Editörler: Çetin M, Ağargün MY, Ebrinç S. Nobel Tıp Kitabevleri,İstanbul,1998, s:92-135.
8. Çetin M. Antisosyal kişilik bozukluğunda komorbit hastalıklar, ayırıcı tanı ve idare. (Editör: Erden C.) Antisosyal Kişilik Bozukluğu , Çorlu, 2002, s:17-29.
9. Çetin M. Alerji Etyolojisinde Psikolojik Faktörlerin Rolü. (Editör: Aydilek R.): Alerjik Hastalıklar ve Bronşial Astma, İstanbul, 1998, Cilt 1, sayfa:277-300.
10. Mesut Çetin, Bölüm 1. Psikiyatrini kısa tarihi, Araştırma ve Klinik Uygulamada Biyolojik Psikiyatri,ŞİZOFRENİ. Editörler M.Emin Ceylan, Mesut Çetin, 3. baskı; Küre İletişim Grubu, İstanbul,2005, sayfa:1-83
11. Mesut Çetin, M.Emin Ceylan Bölüm 2. Genel Bilgiler, Araştırma ve Klinik Uygulamada Biyolojik Psikiyatri,ŞİZOFRENİ. Editörler M.Emin Ceylan, Mesut Çetin, 3. baskı; Küre İletişim Grubu, İstanbul,2005, sayfa:83-125
12. Mesut Çetin, M.Emin Ceylan Bölüm 3. Şizofrenide Temel Psikofarmakoloji, Araştırma ve Klinik Uygulamada Biyolojik Psikiyatri,ŞİZOFRENİ. Editörler M.Emin Ceylan, Mesut Çetin, 3. baskı; Küre İletişim Grubu, İstanbul,2005, sayfa:125-147
13. Mesut Çetin Bölüm 32. Psikiyatride hasta hakları ve etik açısından ilaç uygulaması, Araştırma ve Klinik Uygulamada Biyolojik Psikiyatri,ŞİZOFRENİ. Editörler M.Emin Ceylan, Mesut Çetin, 3. baskı; Küre İletişim Grubu, İstanbul,2005, sayfa:839-849
14. Mesut Çetin, Bölüm 33.Psikofarmakoterapinin genel ilkeleri,hasta hakları ve etik. Araştırma ve Klinik Uygulamada Biyolojik Psikiyatri,ŞİZOFRENİ. Editörler M.Emin Ceylan, Mesut Çetin, 3. baskı; Küre İletişim Grubu, İstanbul, 2005, sayfa:849-861.
15. Mesut Çetin, Bölüm 34. Antipsikotiklerin etki ve yan etkilerinin temelleri. Araştırma veKlinik Uygulamada Biyolojik Psikiyatri,ŞİZOFRENİ. Editörler M.Emin Ceylan, Mesut Çetin, 3. baskı; Küre İletişim Grubu, İstanbul,2005, sayfa:861-881
16. Mesut Çetin, M.Emin Ceylan, Bölüm 35.Tipik antipsikotikler ve antipsikotik tedavisinin klinik ilkeleri. Araştırma ve Klinik Uygulamada Biyolojik Psikiyatri,ŞİZOFRENİ. Editörler M.Emin Ceylan, Mesut Çetin, 3. baskı; Küre İletişim Grubu, İstanbul,2005, sayfa: 991-937
17. Mesut Çetin, Bölüm 36. Yeni antipsikotikler- I. Araştırma ve Klinik Uygulamada Biyolojik Psikiyatri,ŞİZOFRENİ. Editörler M.Emin Ceylan, Mesut Çetin, 3. baskı; Küre İletişim Grubu, İstanbul,2005, sayfa: 937-997.
18. Mesut Çetin, Bölüm 37. Yeni antipsikotikler- II. Araştırma ve Klinik Uygulamada Biyolojik Psikiyatri,ŞİZOFRENİ. Editörler M.Emin Ceylan, Mesut Çetin, 3. baskı; Küre İletişim Grubu, İstanbul,2005, sayfa:997-1019.
19. Mesut Çetin, Bölüm 38. Klinik uygulamada yeni antipsikotikler ve yan etkileri. Araştırma ve Klinik Uygulamada Biyolojik Psikiyatri,ŞİZOFRENİ. Editörler M.Emin Ceylan, Mesut Çetin, 3. baskı; Küre İletişim Grubu, İstanbul,2005, sayfa:1019-1067.
20. Mesut Çetin, Bölüm 39. Yeni antipsikotikler ile ilgili çeşitlikonular. Araştırma ve Klinik Uygulamada Biyolojik Psikiyatri, ŞİZOFRENİ. Editörler M.Emin Ceylan, Mesut Çetin, 3. baskı; Küre İletişim Grubu, İstanbul,2005, sayfa:1067-1117
21. Mesut Çetin, Bölüm 53. Özel durumlarda ilaç kullanımı. Araştırma ve Klinik Uygulamada Biyolojik Psikiyatri, ŞİZOFRENİ. Editörler M.Emin Ceylan, Mesut Çetin, 3. baskı; Küre İletişim Grubu, İstanbul,2005, sayfa: 1383-1403
22. Mesut Çetin, M.Emin Ceylan, Bölüm 55. Şizofrenide kullanılan testler. Araştırma ve Klinik Uygulamada Biyolojik Psikiyatri, ŞİZOFRENİ. Editörler M.Emin Ceylan, Mesut Çetin, 3. baskı; Küre İletişim Grubu, İstanbul,2005, sayfa: 1178-1271.
23. M. Emin Ceylan, Mesut Çetin, Bölüm 56. Şizofrenide kullanılan testler Araştırma ve Klinik Uygulamada Biyolojik Psikiyatri, ŞİZOFRENİ. Editörler 3. baskı; Küre İletişim Grubu, İstanbul,2005,1423-1496
24. M. Emin Ceylan, Mesut Çetin, Araştırma ve Klinik Uygulamada Biyolojik Psikiyatri, ŞİZOFRENİ. Editörler 3. baskı; Küre İletişim Grubu, İstanbul,2005 (Kitap, TSK eser yazma beratı verilmiştir)
25. Mesut Çetin, Psikiyatride Etik, Klinik Psikiyatri, Kaplan Sadock's KLİNİK PSİKİYATRİ EL KİTABI H. Aydın, A.Bozkurt (cev editörleri), Güneş Kitabevi,Ankara,2005, s.615-619
26. Mesut Çetin, Servet Ebrinç, (editörler) 1.Ulusal Psikofarmakoloji Kongresi 14- 17 Aralık 2005, İstanbul ,Bildiri Özet Kitabı İstanbul,2005
27.Mesut Çetin, Servet Ebrinç, (editörler)2.Ulusal Psikofarmakoloji Kongresi Bildiri Özet Kitabı, İstanbul 2007
|
